EMBL institutional partnerships are close cooperative affiliations between EMBL and external institutions of comparable standard, vision and international orientation. Working relationships at the institutional level are based on shared institutional goals and scientific synergy or complementarity. The aim is to leverage the EMBL model together with the strengths of the partners, to create an interlinked system of excellent institutions that enhance molecular life science in Europe and the world. Read more about EMBL Partnerships in the FAQ >
Involving institutions on or near EMBL campuses, benefiting from shared infrastructure and equipment.
Implementing EMBL’s research strategy and operational model on the national level in member states.
Heidelberg, 28 July 2015 Union makes success With the goal of joining forces to further scientific and medical research, EMBL and the Medical Faculty of the University of Heidelberg have renewed the successful Molecular Medicine Partnership Unit (MMPU) agreement until 2025. The two complementary research institutions will continue to share data and resources, and together achieve scientific and medical breakthroughs that each individually may not have been able to make. “This kind of close collaboration really bridges the gap between basic and medical research and brings strong additional value to both institutions,” explains Matthias Hentze, Director of EMBL.
Hinxton, 8 March 2015 Supporting women in science The Wellcome Genome Campus is marking International Women’s Day 2015 by giving its first Best Practice Award for Supporting Women in Science. The recipients are John Overington of EMBL-EBI and Laura Huckins of the Wellcome Trust Sanger Institute. Everyone on campus, scientific and non-scientific alike, were invited to nominate a colleague who had made a positive difference to women’s careers.
Heidelberg, 6 February 2015 The battle for iron The search for therapies against anaemia of chronic disease (ACD) could take on new directions thanks to a study published today in Blood. In it, scientists in the Molecular Medicine Partnership Unit, a joint venture of EMBL and Heidelberg University Clinic, have found a hitherto unknown way through which mice starve pathogens of iron.
Grenoble, 19 November 2014 In full view Scientists looking to understand – and potentially thwart – the influenza virus now have a much more encompassing view, thanks to the first complete structure of one of the flu virus’ key machines. The structure, obtained by scientists at EMBL Grenoble, allows researchers to finally understand how the machine works as a whole, and could prove instrumental in designing new drugs to treat serious flu infections and combat flu pandemics.